Table 1.
Japanese Association for Acute Medicine (JAAM) | International Society of Thrombosis and Hemostasis (ISTH) | ||
---|---|---|---|
SIRS* criteria | Platelet count | ||
≥3 | +1 | <50 × 109/l | +2 |
0 to 2 | 0 | ≥50 <100 × 109/l | +1 |
Platelet count | ≥100 × 109/l | 0 | |
<80 × 109/l or >50% decrease within 24 hours | +3 | Elevated fibrin-related markera | |
≥80 <120 × 109/l or >30% decrease within 24 hours | +1 | Strong increase | +3 |
≥120 × 109/l | 0 | Moderate increase | +2 |
Prothrombin time (value of patient/normal value) | No increase | 0 | |
≥1.2 | +1 | Prolonged prothrombin time | |
<1.2 | 0 | ≥6 seconds | +2 |
Fibrin/fibrinogen degradation products | ≥3 <6 seconds | +1 | |
≥25 mg/l | +3 | <3 seconds | 0 |
≥10 <25 mg/l | +1 | Fibrinogen level | |
<10 mg/l | 0 | <100 g/ml | +1 |
Diagnosis | ≥100 g/ml | 0 | |
If, ≥4, there is positive diagnosis of DIC. | Diagnosis | ||
If >5, there is positive diagnosis of overt DIC. | |||
If <5, suggestive (not affirmative) for non-overt DIC. |
Systemic Inflammatory Response Syndrome